Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1985 1
1986 1
1987 2
1988 2
1989 2
1990 3
1991 2
1992 3
1993 2
1994 6
1995 6
1996 5
1997 5
1998 10
1999 12
2000 10
2001 8
2002 1
2003 1
2004 2
2005 4
2006 9
2007 3
2008 4
2009 6
2010 20
2011 19
2012 9
2013 5
2014 3
2015 3
2016 7
2017 5
2018 15
2019 11
2020 13
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Results by year
Filters applied: . Clear all
Page 1
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.
Hamanaka N, Nakanishi Y, Mizuno T, Horiguchi-Takei K, Akiyama N, Tanimura H, Hasegawa M, Satoh Y, Tachibana Y, Fujii T, Sakata K, Ogasawara K, Ebiike H, Koyano H, Sato H, Ishii N, Mio T. Hamanaka N, et al. Among authors: mio t. Cancer Res. 2019 Nov 15;79(22):5734-5745. doi: 10.1158/0008-5472.CAN-18-3376. Epub 2019 Aug 7. Cancer Res. 2019. PMID: 31391186 Free article.
Impact of COVID-19 pandemic on lung cancer treatment scheduling.
Fujita K, Ito T, Saito Z, Kanai O, Nakatani K, Mio T. Fujita K, et al. Among authors: mio t. Thorac Cancer. 2020 Oct;11(10):2983-2986. doi: 10.1111/1759-7714.13615. Epub 2020 Aug 12. Thorac Cancer. 2020. PMID: 32790028 Free PMC article.
The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor.
Nakanishi Y, Akiyama N, Tsukaguchi T, Fujii T, Sakata K, Sase H, Isobe T, Morikami K, Shindoh H, Mio T, Ebiike H, Taka N, Aoki Y, Ishii N. Nakanishi Y, et al. Among authors: mio t. Mol Cancer Ther. 2014 Nov;13(11):2547-58. doi: 10.1158/1535-7163.MCT-14-0248. Epub 2014 Aug 28. Mol Cancer Ther. 2014. PMID: 25169980 Free article.
212 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page